Eesti - eesti - Ravimiamet

us pharmacia sp. z o.o. - ibuprofeen - õhukese polümeerikattega tablett - 400mg 12tk; 400mg 8tk; 400mg 6tk; 400mg 20tk; 400mg 48tk

Eesti - eesti - Ravimiamet

us pharmacia sp. z o.o. - ibuprofeen - õhukese polümeerikattega tablett - 200mg 50tk; 200mg 20tk; 200mg 96tk; 200mg 8tk; 200mg 4tk; 200mg 30tk; 200mg 2tk; 200mg 10tk; 200mg 6tk

Eesti - eesti - Ravimiamet

us pharmacia sp. z o.o. - paratsetamool - suukaudne suspensioon - 40mg 1ml 85ml 1tk

Eesti - eesti - Ravimiamet

us pharmacia sp. z o.o. - ibuprofeen - pehmekapsel - 400mg 12tk; 400mg 30tk; 400mg 4tk; 400mg 6tk

Eesti - eesti - Ravimiamet

us pharmacia sp. z o.o. - paratsetamool - pehmekapsel - 500mg 24tk; 500mg 14tk; 500mg 8tk; 500mg 26tk; 500mg 30tk; 500mg 6tk; 500mg 2tk; 500mg 22tk

Eesti - eesti - Ravimiamet

us pharmacia sp. z o.o. - ibuprofeen+pseudoefedriin - kaetud tablett - 200mg+30mg 24tk; 200mg+30mg 20tk; 200mg+30mg 12tk; 200mg+30mg 10tk; 200mg+30mg 6tk

Eesti - eesti - Ravimiamet

us pharmacia sp. z o.o. - etofenamaat - geel - 100mg 1g 100g 1tk; 100mg 1g 50g 1tk

Eesti - eesti - Ravimiamet

pharmacia & upjohn - alprostadiil - infusioonilahuse kontsentraadi pulber - 0,5mg 1ml 1ml 5tk

Eesti - eesti - Ravimiamet

pharmacia & upjohn limited - kabergoliin - tablett - 0,5mg 8tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

glaxosmithkline trading services - mepolizumab - astma - ravimid hingamisteede obstruktiivsete haiguste, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.